A tiny but quickly increasing proportion of American teenagers started taking Novo Nordisk’s NONOb.CO weight-loss medication Wegovy last year which is being considered a potent new tool to combat the nation’s record rates of paediatric obesity, as per statistics exclusively obtained by Reuters.
According to US insurance claims data…
Continue Reading
News Source: www.thenews.com.pk
Leave a Reply
You must be logged in to post a comment.